A cloud-based bioinformatic analytic infrastructure and Data Management Core for the Expanded Program on Immunization Consortium.
Bioinformatics
cloud computing
data management
systems biology
vaccinology
Journal
Journal of clinical and translational science
ISSN: 2059-8661
Titre abrégé: J Clin Transl Sci
Pays: England
ID NLM: 101689953
Informations de publication
Date de publication:
22 Sep 2020
22 Sep 2020
Historique:
entrez:
5
5
2021
pubmed:
6
5
2021
medline:
6
5
2021
Statut:
epublish
Résumé
The Expanded Program for Immunization Consortium - Human Immunology Project Consortium study aims to employ systems biology to identify and characterize vaccine-induced biomarkers that predict immunogenicity in newborns. Key to this effort is the establishment of the Data Management Core (DMC) to provide reliable data and bioinformatic infrastructure for centralized curation, storage, and analysis of multiple de-identified "omic" datasets. The DMC established a cloud-based architecture using Amazon Web Services to track, store, and share data according to National Institutes of Health standards. The DMC tracks biological samples during collection, shipping, and processing while capturing sample metadata and associated clinical data. Multi-omic datasets are stored in access-controlled Amazon Simple Storage Service (S3) for data security and file version control. All data undergo quality control processes at the generating site followed by DMC validation for quality assurance. The DMC maintains a controlled computing environment for data analysis and integration. Upon publication, the DMC deposits finalized datasets to public repositories. The DMC architecture provides resources and scientific expertise to accelerate translational discovery. Robust operations allow rapid sharing of results across the project team. Maintenance of data quality standards and public data deposition will further benefit the scientific community.
Identifiants
pubmed: 33948273
doi: 10.1017/cts.2020.546
pii: S2059866120005464
pmc: PMC8057481
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e52Informations de copyright
© The Association for Clinical and Translational Science 2020.
Déclaration de conflit d'intérêts
OL is a named inventor on patents related to vaccine adjuvants and in vitro modeling of human immunity. The other authors have no conflicts of interest to declare.
Références
J Biomed Inform. 2009 Apr;42(2):377-81
pubmed: 18929686
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
J Med Libr Assoc. 2015 Jul;103(3):154-6
pubmed: 26213510
J Med Libr Assoc. 2020 Jan;108(1):29-35
pubmed: 31897049
PLoS Comput Biol. 2018 Jun 14;14(6):e1006144
pubmed: 29902176
Sci Data. 2016 Mar 15;3:160018
pubmed: 26978244
Methods Mol Biol. 2016;1375:25-39
pubmed: 25863787
Front Pediatr. 2020 Apr 30;8:197
pubmed: 32426309
Perspect Clin Res. 2014 Oct;5(4):159-66
pubmed: 25276625
J Biomed Inform. 2019 Jul;95:103208
pubmed: 31078660
PLoS Comput Biol. 2018 Mar 29;14(3):e1005994
pubmed: 29596416
PLoS Med. 2005 Aug;2(8):e124
pubmed: 16060722
J Am Med Inform Assoc. 2007 Jul-Aug;14(4):478-88
pubmed: 17460139
Sci Data. 2018 Feb 27;5:180015
pubmed: 29485622
Nat Commun. 2019 Mar 12;10(1):1092
pubmed: 30862783